Failure of evidencebased cancer care in the United States the association between rectal cancer treatment, cancer center volume, and geography

Annals of Surgery

Volumn 260, Issue 4, 2014, Pages 625-632

  Monson, John R T ^a   Probst, Christian P ^a   Wexner, Steven D ^b   Remzi, Feza H ^b   Fleshman, James W ^c   GarciaAguilar, Julio ^d   Chang, George J ^e   Dietz, David W ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adjuvant chemoradiotherapy; Centers of Excellence; Neoadjuvant chemoradiotherapy; rectal cancer; treatment disparities

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; CANCER CENTER; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RECURRENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; COMORBIDITY; CONFERENCE PAPER; EVIDENCE BASED PRACTICE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH INSURANCE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; RECTUM CANCER; RETROSPECTIVE STUDY; SOCIAL STATUS; TREATMENT FAILURE; UNITED STATES; ADJUVANT THERAPY; ARTICLE; EVIDENCE BASED MEDICINE; GEOGRAPHY; HIGH VOLUME HOSPITAL; RECTUM TUMOR; STATISTICS; UTILIZATION REVIEW;

AGED; CANCER CARE FACILITIES; CHEMORADIOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; FEMALE; GEOGRAPHY; GUIDELINE ADHERENCE; HOSPITALS, HIGH-VOLUME; HUMANS; MALE; NEOADJUVANT THERAPY; PRACTICE GUIDELINES AS TOPIC; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84908341526     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000000928     Document Type: Conference Paper

References (31)

1. National Cancer Institute. SEER Cancer Statistics Review (CSR) 1975- 2010. 2013. Available at http://seer.cancer.gov/archive/csr/1975 2010/. Accessed January 10, 2014.
2. Loos M, Quentmeier P, Schuster T, et al. Effect of preoperative radio( chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis. Ann Surg Oncol. 2013;20:1816-1828.
3. Ceelen W, Pattyn P. Total mesorectal excision in the treatment of rectal cancer: a review. Acta Chir Belg. 2000;100:94-99.
4. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery- the clue to pelvic recurrence? Br J Surg. 1982;69:613-616.
5. Ridgway PF, Darzi AW. The role of total mesorectal excision in the management of rectal cancer. Cancer Control. 2003;10:205-211.
6. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. New Engl J Med. 2001;345:638-646.
7. Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012;30:1926-1933.
8. Popek S, Tsikitis VL. Neoadjuvant vs adjuvant pelvic radiotherapy for locally advanced rectal cancer: which is superior? World J Gastroenterol. 2011;17:848-854.
9. Benson AB, III, Bekaii-Saab T, Chan E, et al. Rectal cancer. J Natl Compr Cancer Netw. 2012;10:1528-1564.
10. Monson JR, Weiser MR, Buie WD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2013;56:535-550.
11. Tjandra JJ, Kilkenny JW, BuieWD, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum. 2005;48:411-423.
12. Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683-690.
13. American College of Surgeons. Facility Oncology Registry Data Standards: December 18, 2012. Available at https://www.facs.org/quality-programs/ cancer/ncdb/registrymanuals/cocmanuals/fordsmanual. Published 2012. Accessed January 7, 2014.
14. Deyo RA, Cherkin DC, CiolMA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
15. Gerard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol. 2006;24:4620-4625.
16. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. New Engl J Med. 2004;351:1731-1740.
17. Abbas MA, Chang GJ, Read TE, et al. Optimizing rectal cancer management: analysis of current evidence. Dis Colon Rectum. 2014;57:252-259.
18. Dietz DW, Consortium for Optimizing Surgical Treatment of Rectal Cancer. Multidisciplinary management of rectal cancer: the OSTRICH. J Gastrointest Surg. 2013;17:1863-1868.
19. Birchall M, Bailey D, King P. Effect of process standards on survival of patients with head and neck cancer in the south and west of England. Br J Cancer. 2004;91:1477-1481.
20. Chang JH, Vines E, Bertsch H, et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer. 2001;91:1231-1237.
21. Coory M, Gkolia P, Yang IA, et al. Systematic review of multidisciplinary teams in the management of lung cancer. Lung Cancer. 2008;60:14-21.
22. Gabel M, Hilton NE, Nathanson SD. Multidisciplinary breast cancer clinics. Do they work? Cancer. 1997;79:2380-2384.
23. Stephens MR, Lewis WG, Brewster AE, et al. Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer. Dis Esophagus. 2006;19:164-171.
24. Wille-Jorgensen P, Sparre P, Glenthoj A, et al. Result of the implementation of multidisciplinary teams in rectal cancer. Colorectal Dis. 2013;15:410-413.
25. Burton S, Brown G, Daniels IR, et al. MRI directed multidisciplinary team preoperative treatment strategy: the way to eliminate positive circumferential margins? Br J Cancer. 2006;94:351-357.
26. Khani MH, Smedh K. Centralization of rectal cancer surgery improves longterm survival. Colorectal Dis. 2010;12:874-879.
27. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med. 1979;301:1364-1369.
28. Stitzenberg KB, Meropol NJ. Trends in centralization of cancer surgery. Ann Surg Oncol. 2010;17:2824-2831.
29. Bilimoria KY, Bentrem DJ, Talamonti MS, et al. Risk-based selective referral for cancer surgery: a potential strategy to improve perioperative outcomes. Ann Surg. 2010;251:708-716.
30. Russell MC, You YN, Hu CY, et al. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013;148:769-777.
31. Weiss JM, Smith MA, Pickhardt PJ, et al. Predictors of colorectal cancer screening variation among primary-care providers and clinics. Am J Gastroenterol. 2013;108:1159-1167.